09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

FP-COR-SU 342 (9)<br />

Initial Therapy <strong>of</strong> Suppurative Microbial Keratitis in Iraq<br />

Al-Shakarchi Faiz (1)<br />

1. Medical College/ Al-Mustansiriya University<br />

Aim: To provide data based guidelines for selection <strong>of</strong> an appropriate initial<br />

therapy for management suppurative microbial keratitis (SMK) in Iraq.<br />

Methods: This case series study enrolled patients with clinical signs <strong>of</strong><br />

suppurative keratitis suspected to be microbial, presented prospectively at Ibn<br />

Al-Haetham Teaching Eye Hospital from April 2002 through March 2005. Initial<br />

therapy started with ciPr<strong>of</strong>loxacin 0.3% eye- drops. Subsequent treatment<br />

depends on clinical response and cultures’ results.<br />

Results: Out <strong>of</strong> 396 cases enrolled, positive cultures were obtained in 232<br />

cases (58.6%). The predominating agents isolated were Gram-positive cocci<br />

75 cases (18.9%); Pseudomonas 68 cases (17.2%); and fungi species 74<br />

cases (18.7%). Treatment was initiated with ciPr<strong>of</strong>loxacin eye- drops in 364<br />

cases, and favorable response was recorded in 185 cases (50.8%), addition<br />

<strong>of</strong> other antimicrobial drugs was required in 56 cases (15.4%), while failure <strong>of</strong><br />

treatment was recorded in 123 cases (33.8%).<br />

Conclusion: Use <strong>of</strong> ciPr<strong>of</strong>loxacin eye drops alone as an initial therapy cannot<br />

cover most <strong>of</strong> the causative agents <strong>of</strong> SMK in Iraq. Addition <strong>of</strong> another drug can<br />

provide a better coverage for the predominating causative agents. The choice<br />

<strong>of</strong> this additional drug is based on the suspected infecting agent depending on<br />

the regional predisposing factors, and the clinical features.<br />

FP-COR-SU 342 (10)<br />

Clinical Pr<strong>of</strong>ile and Visual Outcomes in Herpes Zoster Ophthalmicus<br />

Bose Jayeeta (1) , Karki Manisha (1)<br />

1. Venu Eye Institute and Research Center<br />

Purpose: To study clinical pr<strong>of</strong>ile and visual outcomes in Herpes Zoster<br />

Ophthalmicus (HZO).<br />

Methods: Retrospective review <strong>of</strong> 18 eyes <strong>of</strong> 18 patients <strong>of</strong> HZO between<br />

January to December 2010 was done. Demographics, clinical presentation,<br />

treatment, visual outcomes and systemic associations were noted.<br />

Results: Mean age was 34.5 years. Systemic diseases associated were<br />

Hodgkin’s lymphoma, HIV, Diabetes Mellitus. All patients had rashes on<br />

forehead with tip <strong>of</strong> nose involvement in 5. Conjunctivitis was present in 7<br />

patients. Corneal involvement included nummular keratitis in 3, superficial<br />

punctate keratitis (SPK) in 8,neurotrophic keratitis in 4 and disciform keratitis<br />

in 1. 5 patients had keratouveitis.16 had presenting visual acuity from 6/6 to<br />

6/60,1HM and1 PL+. Improvement <strong>of</strong> visual acuity was seen in 17 patients with<br />

exception in the HIV positive patient (who was lost to follow up).<br />

Conclusion: Most common ocular presentation was conjunctivitis and SPK. All<br />

5 patients with keratouveitis had positive Hutchinson’s sign which correlates<br />

with more severe ocular involvement. Improvement <strong>of</strong> visual acuity was seen<br />

in 17 patients (94.0%). Hence, with appropriate treatment and follow up there<br />

is good visual outcome and minimal complications in HZO patients.<br />

326<br />

FP-COR-SU 342 (11)<br />

Limbal Autograft After Excision <strong>of</strong> Primary and Recurrent Pterygium<br />

Doroodgar Farideh (1)<br />

1. Tehran University <strong>of</strong> Medical Sciences<br />

Purpose: To report the result <strong>of</strong> limbal autografting in primary and recurrent<br />

pterygium.<br />

Methods: In this case series, all patients who were referred for treatment <strong>of</strong><br />

pterygium were included. Indications <strong>of</strong> surgery included chronic ocular<br />

irritation, impaired or threatened vision, ocular motility problem and cosmetic<br />

reasons. Under subconjunctional anesthesia, pterygium was removed from the<br />

cornea and conjunctiva and a crescent shape limbal tissue from supratemporal<br />

region <strong>of</strong> the same or the sound eye was then prepared and sutured in the area<br />

<strong>of</strong> pterygium removal. Postoperatively, topical betamethasone for 4 weeks and<br />

antibiotic for 2 weeks were prescribed.<br />

Results: Two-hundred and three eyes were studied <strong>of</strong> which, 125 eyes (61.6%)<br />

had primary and 78 eyes (38.4%) had recurrent pterygium. After at least one<br />

year <strong>of</strong> follow-up, only 9 eyes (4.5%) had recurrence larger than 1 mm. Visual<br />

acuity and refraction improved in 60% <strong>of</strong> the eyes. No significant complication<br />

occurred except appearance <strong>of</strong> a fibrous tissue in the donor site which was not<br />

progressive and was covered by the upper lid in all cases.<br />

Conclusions: Surgical removal together with limbal autograft is a safe and<br />

effective method for treatment <strong>of</strong> primary and recurrent pterygium.<br />

Free Paper: Oncology<br />

Sun 19 Feb 15:30 - 17:00 Conference Room B4<br />

FP-ONC-SU 343 (1)<br />

Vascular Tumors <strong>of</strong> the Iris. They do Exist.<br />

Shields Jerry (1) , Bianciotto Carlos (1) , Kligman Brad (1) , Shields Carol (1)<br />

1. Wills Eye Institute<br />

Methods: Iris vascular tumors are believed to be rare or even nonexistent. A<br />

review <strong>of</strong> patients with diagnosis <strong>of</strong> iris vascular tumor from the Ocular<br />

Oncology Service, Wills Eye Institute.<br />

Results: There were 53 eyes in 45 patients. Diagnoses included racemose<br />

hemangioma in 41 eyes, cavernous hemangioma in 4 eyes (capillary<br />

hemangioma in 1 eye, varix in 3 eyes, microhemangiomatosis in 6 eyes <strong>of</strong> 3<br />

patients. Histopathologic confirmation <strong>of</strong> the diagnosis was available in one eye<br />

with cavernous hemangioma and one eye with varix. Racemose hemangioma<br />

remained stable in all cases and posed no complications. Solitary cavernous<br />

hemangioma was associated with recurrent hyphema and had no systemic<br />

implications. One iris cavernous hemangioma was part <strong>of</strong> a syndrome with<br />

visceral, brain, and cutaneous cavernous hemangiomas. There were 3<br />

patients with microhemangiomatosis, each <strong>of</strong> whom had bilateral pupillary<br />

margin involvement and recurrent hyphemas.<br />

Conclusions: Although the existence <strong>of</strong> iris vascular tumors has been<br />

challenged, there are well documented examples <strong>of</strong> racemose<br />

hemangioma, cavernous hemangioma, capillary hemangioma, varix, and<br />

microhemangiomatosis. Each has characteristic features and some can<br />

cause hyphema. Although most are solitary lesions confined to the iris, some<br />

(cavernous hemangioma and microhemangiomatosis) may have systemic<br />

associations.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!